196170.KQ
ALTEOGEN Inc.
KOE · Healthcare · Biotechnology · KR
KRW 254,000.00
−0.59%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- KRW 968
- Revenue estimate
- KRW 114.0B
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- KRW 262
- EPS estimate
- KRW 262
- Revenue actual
- KRW 54.9B
- Revenue estimate
- KRW 57.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +0.0%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | KRW 262 | KRW 262 | In line | KRW 54.9B |
| May 8, 2026 | KRW 903 | KRW 903 | In line | KRW 71.6B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026